HK Stock MarketDetailed Quotes

03347 TIGERMED

Watchlist
  • 33.600
  • +2.600+8.39%
Market Closed Apr 26 16:08 CST
29.31BMarket Cap15.69P/E (TTM)

TIGERMED Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
-8.00%1.66B
4.21%7.38B
4.52%5.65B
3.25%3.71B
-0.73%1.8B
35.91%7.09B
59.23%5.41B
74.78%3.59B
101.55%1.82B
63.32%5.21B
Operating income
-8.00%1.66B
4.21%7.38B
4.52%5.65B
3.25%3.71B
-0.73%1.8B
35.91%7.09B
59.23%5.41B
74.78%3.59B
101.55%1.82B
63.32%5.21B
Cost of sales
----
-6.12%-4.56B
----
-3.16%-2.24B
----
-45.01%-4.3B
----
-99.72%-2.18B
----
-75.58%-2.97B
Operating expenses
5.23%-1.03B
-6.12%-4.56B
-4.12%-3.37B
-3.16%-2.24B
2.06%-1.09B
-45.01%-4.3B
-79.13%-3.24B
-99.72%-2.18B
-132.28%-1.11B
-75.58%-2.97B
Gross profit
-12.21%628.12M
1.26%2.82B
5.12%2.28B
3.38%1.47B
1.37%715.52M
23.90%2.79B
36.58%2.17B
46.69%1.42B
66.79%705.85M
49.54%2.25B
Selling expenses
-3.43%-46.45M
-24.97%-187.32M
-22.94%-132.7M
-11.19%-89M
-16.61%-44.91M
-15.84%-149.89M
-12.61%-107.94M
-20.08%-80.04M
-21.74%-38.51M
-33.98%-129.4M
Administrative expenses
-3.60%-177.07M
-3.01%-662.7M
-14.39%-527.54M
-8.96%-350.17M
-7.54%-170.92M
-15.95%-643.32M
-18.67%-461.2M
-30.28%-321.38M
-39.22%-158.95M
-38.44%-554.81M
Research and development expenses
0.95%-63.91M
-11.48%-261.56M
-14.20%-195.34M
-15.89%-128.08M
-13.22%-64.52M
-10.76%-234.62M
-10.50%-171.06M
-18.80%-110.52M
-21.33%-56.99M
-35.23%-211.83M
Profit from asset sales
32,651.46%1.15M
----
282.55%45.22K
----
41.47%-3.54K
----
95.63%-24.77K
----
-20.24%-6.05K
----
Revaluation surplus
-92.77%12.75M
----
76.46%710.39M
----
40.98%176.41M
----
-63.97%402.59M
----
-71.44%125.13M
----
-Changes in the fair value of other assets
-92.77%12.75M
----
76.46%710.39M
----
40.98%176.41M
----
-63.97%402.59M
----
-71.44%125.13M
----
Impairment and provision
11.22%-18.4M
-177.10%-68.1M
-0.74%-45.34M
-4.81%-29.78M
-76.90%-20.73M
-0.61%-24.58M
-152.89%-45.01M
-177.13%-28.41M
-105.74%-11.72M
-342.44%-24.43M
-Other impairment is provision
11.22%-18.4M
-177.10%-68.1M
-0.74%-45.34M
-4.81%-29.78M
-76.90%-20.73M
-0.61%-24.58M
-152.89%-45.01M
-177.13%-28.41M
-105.74%-11.72M
-342.44%-24.43M
Special items of operating profit
-61.93%11.78M
-4.57%863.91M
25.78%138.34M
20.36%718.98M
-50.70%30.94M
-61.84%905.28M
-17.65%109.98M
-48.26%597.37M
79.40%62.75M
67.65%2.37B
Operating profit
-44.66%340.28M
-5.06%2.5B
17.21%2.21B
7.65%1.59B
-1.46%614.94M
-28.70%2.64B
-13.08%1.88B
-13.47%1.48B
-10.08%624.06M
62.67%3.7B
Financing cost
37.34%21.92M
-44.14%-119.9M
-11.06%105.76M
-70.18%-52.82M
-47.37%15.96M
-233.92%-83.18M
-32.28%118.91M
-290.77%-31.04M
-51.30%30.32M
50.94%-24.91M
Share of profits of associates
----
164.52%105.18M
----
79.22%63.72M
----
177.13%39.76M
----
4,817.84%35.56M
----
509.01%14.35M
Special items of earning before tax
2.21%167.98K
----
-45.03%2.75M
----
-89.86%164.35K
----
201.12%4.99M
----
87.04%1.62M
----
Earning before tax
-42.58%362.36M
-4.04%2.49B
15.38%2.31B
8.06%1.6B
-3.80%631.06M
-29.67%2.59B
-14.12%2.01B
-12.83%1.48B
-13.36%656M
66.17%3.69B
Tax
20.63%-49.79M
-7.96%-338.61M
-22.61%-286.62M
-17.76%-191.06M
23.52%-62.74M
-7.10%-313.65M
-55.66%-233.77M
-56.70%-162.24M
-137.02%-82.03M
-54.38%-292.86M
After-tax profit from continuing operations
-45.00%312.57M
-5.68%2.15B
14.42%2.03B
6.87%1.41B
-0.98%568.33M
-32.84%2.28B
-18.92%1.77B
-17.35%1.32B
-20.56%573.97M
67.28%3.4B
Earning after tax
-45.00%312.57M
-5.68%2.15B
14.42%2.03B
6.87%1.41B
-0.98%568.33M
-32.84%2.28B
-18.92%1.77B
-17.35%1.32B
-20.56%573.97M
67.28%3.4B
Minority profit
59,975.46%77.5M
-52.83%125.08M
-11.54%148.24M
-84.28%19.75M
-100.23%-129.43K
-48.76%265.17M
-58.59%167.58M
-62.42%125.62M
-79.20%55.55M
85.35%517.54M
Profit attributable to shareholders
-58.65%235.07M
0.52%2.03B
17.13%1.88B
16.47%1.39B
9.65%568.46M
-29.98%2.02B
-9.90%1.6B
-5.39%1.19B
13.82%518.42M
64.40%2.88B
Basic earnings per share
-59.09%0.27
0.43%2.34
16.67%2.17
16.67%1.61
10.00%0.66
-29.82%2.33
-9.27%1.86
-4.83%1.38
15.38%0.6
50.91%3.32
Diluted earnings per share
-59.09%0.27
0.43%2.34
16.67%2.17
15.94%1.6
10.00%0.66
-29.61%2.33
-8.82%1.86
-4.17%1.38
15.38%0.6
51.14%3.31
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited
--
--
--
Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited
--
--
--
Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover -8.00%1.66B4.21%7.38B4.52%5.65B3.25%3.71B-0.73%1.8B35.91%7.09B59.23%5.41B74.78%3.59B101.55%1.82B63.32%5.21B
Operating income -8.00%1.66B4.21%7.38B4.52%5.65B3.25%3.71B-0.73%1.8B35.91%7.09B59.23%5.41B74.78%3.59B101.55%1.82B63.32%5.21B
Cost of sales -----6.12%-4.56B-----3.16%-2.24B-----45.01%-4.3B-----99.72%-2.18B-----75.58%-2.97B
Operating expenses 5.23%-1.03B-6.12%-4.56B-4.12%-3.37B-3.16%-2.24B2.06%-1.09B-45.01%-4.3B-79.13%-3.24B-99.72%-2.18B-132.28%-1.11B-75.58%-2.97B
Gross profit -12.21%628.12M1.26%2.82B5.12%2.28B3.38%1.47B1.37%715.52M23.90%2.79B36.58%2.17B46.69%1.42B66.79%705.85M49.54%2.25B
Selling expenses -3.43%-46.45M-24.97%-187.32M-22.94%-132.7M-11.19%-89M-16.61%-44.91M-15.84%-149.89M-12.61%-107.94M-20.08%-80.04M-21.74%-38.51M-33.98%-129.4M
Administrative expenses -3.60%-177.07M-3.01%-662.7M-14.39%-527.54M-8.96%-350.17M-7.54%-170.92M-15.95%-643.32M-18.67%-461.2M-30.28%-321.38M-39.22%-158.95M-38.44%-554.81M
Research and development expenses 0.95%-63.91M-11.48%-261.56M-14.20%-195.34M-15.89%-128.08M-13.22%-64.52M-10.76%-234.62M-10.50%-171.06M-18.80%-110.52M-21.33%-56.99M-35.23%-211.83M
Profit from asset sales 32,651.46%1.15M----282.55%45.22K----41.47%-3.54K----95.63%-24.77K-----20.24%-6.05K----
Revaluation surplus -92.77%12.75M----76.46%710.39M----40.98%176.41M-----63.97%402.59M-----71.44%125.13M----
-Changes in the fair value of other assets -92.77%12.75M----76.46%710.39M----40.98%176.41M-----63.97%402.59M-----71.44%125.13M----
Impairment and provision 11.22%-18.4M-177.10%-68.1M-0.74%-45.34M-4.81%-29.78M-76.90%-20.73M-0.61%-24.58M-152.89%-45.01M-177.13%-28.41M-105.74%-11.72M-342.44%-24.43M
-Other impairment is provision 11.22%-18.4M-177.10%-68.1M-0.74%-45.34M-4.81%-29.78M-76.90%-20.73M-0.61%-24.58M-152.89%-45.01M-177.13%-28.41M-105.74%-11.72M-342.44%-24.43M
Special items of operating profit -61.93%11.78M-4.57%863.91M25.78%138.34M20.36%718.98M-50.70%30.94M-61.84%905.28M-17.65%109.98M-48.26%597.37M79.40%62.75M67.65%2.37B
Operating profit -44.66%340.28M-5.06%2.5B17.21%2.21B7.65%1.59B-1.46%614.94M-28.70%2.64B-13.08%1.88B-13.47%1.48B-10.08%624.06M62.67%3.7B
Financing cost 37.34%21.92M-44.14%-119.9M-11.06%105.76M-70.18%-52.82M-47.37%15.96M-233.92%-83.18M-32.28%118.91M-290.77%-31.04M-51.30%30.32M50.94%-24.91M
Share of profits of associates ----164.52%105.18M----79.22%63.72M----177.13%39.76M----4,817.84%35.56M----509.01%14.35M
Special items of earning before tax 2.21%167.98K-----45.03%2.75M-----89.86%164.35K----201.12%4.99M----87.04%1.62M----
Earning before tax -42.58%362.36M-4.04%2.49B15.38%2.31B8.06%1.6B-3.80%631.06M-29.67%2.59B-14.12%2.01B-12.83%1.48B-13.36%656M66.17%3.69B
Tax 20.63%-49.79M-7.96%-338.61M-22.61%-286.62M-17.76%-191.06M23.52%-62.74M-7.10%-313.65M-55.66%-233.77M-56.70%-162.24M-137.02%-82.03M-54.38%-292.86M
After-tax profit from continuing operations -45.00%312.57M-5.68%2.15B14.42%2.03B6.87%1.41B-0.98%568.33M-32.84%2.28B-18.92%1.77B-17.35%1.32B-20.56%573.97M67.28%3.4B
Earning after tax -45.00%312.57M-5.68%2.15B14.42%2.03B6.87%1.41B-0.98%568.33M-32.84%2.28B-18.92%1.77B-17.35%1.32B-20.56%573.97M67.28%3.4B
Minority profit 59,975.46%77.5M-52.83%125.08M-11.54%148.24M-84.28%19.75M-100.23%-129.43K-48.76%265.17M-58.59%167.58M-62.42%125.62M-79.20%55.55M85.35%517.54M
Profit attributable to shareholders -58.65%235.07M0.52%2.03B17.13%1.88B16.47%1.39B9.65%568.46M-29.98%2.02B-9.90%1.6B-5.39%1.19B13.82%518.42M64.40%2.88B
Basic earnings per share -59.09%0.270.43%2.3416.67%2.1716.67%1.6110.00%0.66-29.82%2.33-9.27%1.86-4.83%1.3815.38%0.650.91%3.32
Diluted earnings per share -59.09%0.270.43%2.3416.67%2.1715.94%1.610.00%0.66-29.61%2.33-8.82%1.86-4.17%1.3815.38%0.651.14%3.31
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited------Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited------Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg